![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
Advertisement
Persons > All
Find below all kinds of persons.Total search results: 8019 | Ordered by Person (ascending)
1 2 3 ... 17 18 19 ... 79 80 81 
  Person |
 Position |
Organisation (Group) |
Country |
|---|---|---|---|
| Emmick, Jeff (Lilly 201706 VP Product Development at Lilly Diabetes) | Research & Development Manager | Eli Lilly (Group) | United States (USA) |
| Enderle, Thilo (Max Planck 202001 Managing Director at Hit Discovery Constance) | Managing Director | Max Planck Society for the Advancement of Science | Germany |
| Endress, Klaus (Endress+Hauser 201309 CEO) | Chief Executive Officer (CEO) | Endress+Hauser (Group) | Switzerland |
| Engel, Jürgen (Æterna Zentaris 200504) | Chief Operating Officer (COO) | Æterna Zentaris (Group) | Canada |
| Engel, Klaus (Evonik 201112 Chairman of Executive Board) | Chief Executive Officer (CEO) | Evonik (Group) | Germany |
| Engel, Sven (Amantec GmbH 201108 Managing Director) | Managing Director | Sacura GmbH | Germany |
| Engeland, Birgit (AltonaBiotec 200810) | n. a. | AltonaBiotec AG | Germany |
| Engelen, Julie (SGS 201802 Investor Relations Manager) | Public Relations Manager / Investor Relations Manager | SGS (Group) | Switzerland |
| Engelhard, Markus (Boehmert & Boehmert 200501–200809–) | Patent Attorney | Boehmert & Boehmert (Patentanwälte) (Group) | Germany |
| Engeser, Marianne (Uni Bonn 200910 Head Div of Mass Spectrometry) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) | Germany |
| Enghild, Jan J. (Aarhus Univ 201106 Professor Laboratory for Proteome Analysis and Protein Characterisation) | Professor | Aarhus University | Denmark |
| Enghofer, Erich (4SC 201406– EVP Oncology + Haematology before Bayer Healthcare) | President/Director/Head Business Group/Unit/Division | 4SC (Group) | Germany |
| England, Claire (Covalent Bonds 2018– before Scott Partnership at Kapler Comms + Phoenix MarCom) | Public Relations Manager / Investor Relations Manager | Covalent Bonds LLC | United States (USA) |
| Englbrecht, Claudia (BIO Deutschland 2013 Public Relations Manager) | public/private partnership | BIO Deutschland e. V. | Germany |
| Engleman, Katie (1AB Media 201903 before Pure Communications) | Public Relations Manager / Investor Relations Manager | 1AB Media (US) | United States (USA) |
| Englerth, Chris (Phlexglobal 202001 Head Global Marketing) | Sales Manager / Marketing Manager | Phlexglobal (Group) | United Kingdom (GB) |
| Engsig, Michael (Vaccibody 202010 CEO) | Chief Executive Officer (CEO) | Vaccibody AS (Euronext Growth Oslo: VACC) | Norway |
| Enns, Timothy L. (KineMed 201401– Chief Investor + Media Relations Officer before Astex/SuperGen) | Public Relations Manager / Investor Relations Manager | KineMed Inc. | United States (USA) |
| Enyedy, Mark J. (ImmunoGen 201705 CEO before Genzyme 200803 President Genzyme Oncology) | Chief Executive Officer (CEO) | ImmunoGen Inc. (Nasdaq: IMGN) | United States (USA) |
| Enzelberger, Markus (Versant Ventures 202003– EIR in Basel before MorphoSys 2002–202002) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Versant Ventures | Switzerland |
| Epping-Jordan, Mark (Addex Pharma –200806 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Addex (Group) | Switzerland |
| Epstein, Barry (Proteomics International 201201 VP Marketing) | Sales Manager / Marketing Manager | Proteomics International Pty Ltd. | Australia |
| Epstein, David M. (Black Diamond Therapeutics 2017– CEO + Co-Founder) | Chief Executive Officer (CEO) | Black Diamond Therapeutics (Group) | United States (USA) |
| Epstein, David R. (Flagship Pioneering 201701– Executive Partner before Novartis –201605 Division Head Pharma LEFT 5/16) | Partner (venture partner) | Flagship Pioneering | United States (USA) |
| Epstein, Jake (Klein Hersh International 202002 Director of Business Development + Finance) | Business Development Manager / Strategy Manager | Klein Hersh International | United States (USA) |
| Erbe, Cornelius (vfa 202001 Managing Director) | Managing Director | VFA (Verband Forschender Arzneimittelhersteller e. V.) | Germany |
| Erdman, Chris (CRISPR Therapeutics 201711 Investor Relations) | Public Relations Manager / Investor Relations Manager | CRISPR Therapeutics (Group) | United States (USA) |
| Erdmann, Till (Myelo Therapeutics 201304– Managing Director) | Managing Director | Myelo Therapeutics GmbH | Germany |
| Erdmann, Winfried (Berthold Technologies 201106 European Sales Manager Bioanalytic) | Sales Manager / Marketing Manager | Berthold Technologies (Group) | Germany |
| Ergun, Elcin (Menarini 201909– CEO before Merck (DE) 201409 Head Global Commerical at Merck Serono) | Chief Executive Officer (CEO) | Menarini (Group) | Italy |
| Erhard, Marcel (AnagnosTec 1998–200912– CSO + co-founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | AnagnosTec Gesellschaft für Analytische Biochemie und Diagnostik mbH | Germany |
| Erhart, Benjamin (High-Tech Gründerfonds 201204 Investment Manager) | Investment Manager | High-Tech Gründerfonds (HTGF) (Group) | Germany |
| Eric Fotheringham (Waters 200601 Senior Product Manager) | Product Manager (personnel) | Waters (Group) | Germany |
| Erlen, Hubertus | n. a. | Bayer (Group) | Germany |
| Erlich, Henry (Roche 201103 Roche Molecular Systems Director of Dept of Human Genetics) | Researcher (industry) | Children’s Hospital Oakland | United States (USA) |
| Ermantraut, Eugen (Clondiag 200502 Managing Director) | Managing Director | Alere (Group) | Germany |
| Ernst, Bettina (Bernina BioInvest 202011 Director + InterAx Biotech 201901– Non-executive Board Member) | Board member, non-executive | Bernina BioInvest AG | Switzerland |
| Ernst, Doreen (Analytik Jena 200809) | n. a. | Endress+Hauser (Group) | Germany |
| Erselius, Jörn R. (Max Planck Innovation Managing Director before Garching Innovation 200311) | Managing Director | Max Planck Society for the Advancement of Science | Germany |
| Erwin, M. Johnston (Eli Lilly 201603 VP Corporate Business Development) | Business Development Manager / Strategy Manager | Eli Lilly (Group) | United States (USA) |
| Eschenfelder, Christina (Rittershaus 201511 Lawyer) | Attorney / Lawyer | Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH | Germany |
| Escher, Adrian (ESBATech 200205 CFO) | Chief Financial Officer (CFO) | Novartis (Group) | Switzerland |
| Escher, Dominik (Belleveue 201001 Managing Partner at BB Pureos Bioventures before ESBATech CEO + Founder) | Managing Partner | Bellevue (Group) | United Kingdom (GB) |
| Escher, Klaus | n. a. | BASF (Group) | Germany |
| Esper, Ralph (Eppendorf 201811– Head of Corporate Communications before Hagebau + Hamburger Sparkasse) | Public Relations Manager / Investor Relations Manager | Eppendorf (Group) | Germany |
| Esposito, Gloria (Artemis 200705– Project Manager) | n. a. | Taconic (Group) | Germany |
| Essakali, Salim (Solis BioDyne 202109– Head of Global Sales + Marketing before Qiagen + Boston Scientific) | Sales Manager / Marketing Manager | Solis BioDyne OÜ | Estonia |
| Essenpreis, Matthias (Roche 201502 CTO of Roche Diagnostics) | Chief Technology/Technical Officer (CTO) | Roche (Group) | United States (USA) |
| Essig, Stuart M. (Wellington Partners 201303– Venture Partner before Integra Life Sciences CEO + Goldman Sachs) | Venture Partner | Wellington Partners (Group) | Germany |
| Essinger, Jacques R. (Symetis 201703 CEO) | Chief Executive Officer (CEO) | Boston Scientific (Group) | Switzerland |
| Esslinger, Christoph (Memo Therapeutics AG 202011 CSO + Co-Founder formerly CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Memo Therapeutics AG | Switzerland |
| Etches, Robert J. (Rob) (Crystal Bioscience 201401 CEO) | Chief Executive Officer (CEO) | Crystal Bioscience Inc. | United States (USA) |
| Ettenberg, Seth (Bayer 202003– CSO BlueRock Therapeutics before Unum Therapeutics + Novartis IBR + CuraGen) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Bayer (Group) | United States (USA) |
| Etzold, Thure (Lion Bioscience 200502–200604 CEO resigned) | Chief Executive Officer (CEO) | 2invest (Group) | Germany |
| Eugster, Rudolf (Tecan 200212–20203 CFO RETIRED 3/20) | Chief Financial Officer (CFO) | Tecan (Group) | Switzerland |
| Eul, Wilfried (Evonik 201207 SVP + Head Catalysts Business Line) | President/Director/Head Business Group/Unit/Division | Evonik (Group) | Germany |
| Euller, Gordon (Apex Ventures 202010 Partner Digital Health) | Partner (venture partner) | Apex Ventures (Group) | Austria |
| Evans, David (Syngenta 200404) | n. a. | Syngenta (Group) | Switzerland |
| Evans, Richard (EKF Diagnostics 201307– COO before Finance Director) | Chief Operating Officer (COO) | EKF Diagnostics (Group) | United Kingdom (GB) |
| Evans, Thomas G. (Tom) (Vaccitech 201908– CSO before CEO before Vical + Novartis + Aeras) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Vaccitech (Group) | United Kingdom (GB) |
| Evans-Freke, Stephen (Celtic Therapeutics 2007 General Partner + Co-Founder) | General Partner (venture partner) | Auven Therapeutics (Group) | United States (USA) |
| Evenden, Anja (Vego Ltd 201401 Marketing Executive) | Sales Manager / Marketing Manager | Vego Ltd. | United Kingdom (GB) |
| Evens, Andrew (Tufts University 201601 Prof at Tufts Univ School of Medicine + Director of Cancer Center) | Professor | Affimed (Group) | Germany |
| Everson, Lloyd (MolecularHealth 201401 CEO of US division before US Oncology Inc) | Chief Executive Officer (CEO) | Molecular Health (Group) | United States (USA) |
| Evertsz, Carl J. G. (MeVis Medical Solutions 200609–201202 CEO LEAVES 3/12) | Chief Executive Officer (CEO) | Varian Medical Systems (Group) | Germany |
| Evnin, Luke (MPM Capital 201307 Managing Director) | Managing Director | MPM Capital (Group) | United States (USA) |
| Ewert, Markus L. E. (Alentis Therapeutics 201904–202007 CEO before Ablynx+ GE Healthcare + Novartis + BC LEFT 7/20) | Chief Executive Officer (CEO) | Alentis Therapeutics AG | Switzerland |
| Eyber, Klaus U. (Kaye Scholer 200407– Attorney + Partner at Kay Scholer in Ffm before Haarmann Hemmelrath) | Attorney / Lawyer | Arnold & Porter LLP | Germany |
| Eylenbosch, Hilde (Biocartis 201611–201904 CCO joined 2013 before Alere + SPD Swiss Precision LEFT 5/19) | Chief Commercial Officer (CCO) | Biocartis (Group) | Belgium |
| Ezickson, Elan (Aveo Pharmaceuticals 201112 CBO) | Chief Business Officer (CBO) | Aveo Pharmaceuticals Inc. | United States (USA) |
| Faber, Christian Jörg (Alytas Therapeutics 201808– Managing Director) | Managing Director | Alytas Therapeutics GmbH | Germany |
| Fáber, René (Sartorius 202010 Head of Bioprocess Solutions Division) | President/Director/Head Business Group/Unit/Division | Sartorius (Group) | Germany |
| Fabro, Scott (Evolva 20107– CCO before Sweet Harvest Foods + ACH Foods + Kerry + Cargill) | Chief Commercial Officer (CCO) | Evolva (Group) | Switzerland |
| Fackler, Thomas | n. a. | Fraunhofer (Group) | Germany |
| Faeh, Urban (Bruker 201001– President Bruker Optics division joined Bruker 1998 as sales manager) | President/Director/Head Business Group/Unit/Division | Bruker BioSciences (Group) | |
| Fafflock, Heike (Bremen 201005– Innovation Manager Health before B.I.T. + hkk) | n. a. | Bremen (govt region) | Germany |
| Fagan, Maria (Regulatory and Quality Solutions 202009 President + Co-Founder) | Chief Executive Officer (CEO) | Regulatory and Quality Solutions (R&G) (Group) | United States (USA) |
| Fagerberg, Jan (Enterome 202103 CMO formerly Micromet 200911 SVP + CMO) | Chief Medical Officer (CMO) | Enterome S.A. | France |
| Fahr, Anne-Marie (Labor Limbach 200909 Head Microbiology) | Laboratory Manager (industry) | Labor Limbach (Group) | Germany |
| Fahrenberg, Jens (Karlsruhe Institute of Technology 201307 Head of Innovation Management Office) | IP Manager | Karlsruhe Institute of Technology (KIT) | Germany |
| Fairey, William (Bill) (MyoKardia 201901– CCO before ChemoCentryx + Actelion + Parke-Davis Pharmaceuticals US) | President/Director/Head Business Group/Unit/Division | Bristol-Myers Squibb (BMS) (Group) | United States (USA) |
| Faisst, Arne-Christian (ABC Biopply 202106 CEO + Quadira Biosciences 202106 CEO) | Chief Executive Officer (CEO) | ABC Biopply AG | Switzerland |
| Fakih, Sarah (CureVac 202007– VP Investor Relations before MorphoSys + Qiagen) | Public Relations Manager / Investor Relations Manager | CureVac N.V. (Nasdaq: CVAC) | Netherlands |
| Falcenberg, Matthias (Forbion 201604– Analyst at Munich Office before at MPI of Biochemistry) | Analyst (Financial / Industry) | Forbion (Group) | Germany |
| Falch, Siegfried (JEOL 201002 Managing Director JEOL (Germany) GmbH) | Managing Director | JEOL (Group) | Germany |
| Falchuk, Jason (BioBridges 201709 President + Founding Partner) | President/Director/Head Business Group/Unit/Division | Adecco (Group) | United States (USA) |
| Falk, Ursula (Dr Falk Pharma 201403 Managing Director) | Managing Director | Dr. Falk Pharma (Group) | Germany |
| Falken, Ulrich (Analyticon Biotechnologies 2007 COO) | Chief Operating Officer (COO) | Analyticon Biotechnologies AG | Germany |
| Fallegger, Florian (Neurosoft Bioelectronics 202103 CTO + Co-Founder) | Chief Technology/Technical Officer (CTO) | Neurosoft Bioelectronics (CH) | Switzerland |
| Fallen, Karen (Touchlight 202010– CEO of Touchlight DNA Servcies before Lonza + Celltech) | Chief Executive Officer (CEO) | Touchlight (Group) | United Kingdom (GB) |
| Fambrough, Douglas M. (Dicerna Pharmaceuticals 201711 CEO) | Chief Executive Officer (CEO) | Dicerna Pharmaceuticals Inc. (Nasdaq: DRNA) | United States (USA) |
| Fang, Nan (Singleron 202203 CEO + Co-Founder before Novogene + Qiagen) | Chief Executive Officer (CEO) | Singleron (Group) | China |
| Fang, Peter (Boehringer 202002 SVP + Head of Therapeutic Area Inflammation) | President/Director/Head Business Group/Unit/Division | Boehringer Ingelheim (Group) | Germany |
| Faraco, Vincenza (University of Naples Federico II 201405) | Researcher (university / research institute) | University of Naples Federico II | Italy |
| Farhangi, Sonja (Stratec 201110 Stratec Molecular GmbH Marketing + Public Relations) | Sales Manager / Marketing Manager | Stratec (Group) | Germany |
| Farid, Ramy (Schrödinger 202011 CEO) | Chief Executive Officer (CEO) | Schrödinger (Group) | United States (USA) |
| Farinelli, Laurent (Fasteris 200901 CEO + co-founder | Chief Executive Officer (CEO) | Fasteris S.A. | Switzerland |
| Farmer, Jeffrey (Brooks Automation 201307 VP + General Manager of Brooks Life Science Systems) | General Manager (management) | Brooks Automation (Group) | United States (USA) |
| Farre, Cecilia (Nanion 201309 Marketing Director) | Sales Manager / Marketing Manager | Nanion (Group) | Germany |
| Farzan, Nima (PaxVax 201507 CEO) | Chief Executive Officer (CEO) | PaxVax (Group) | United States (USA) |
1 2 3 ... 17 18 19 ... 79 80 81
Advertisement
![Picture [iito] No Content Marketing 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-content-marketing.jpg)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px](/banner/iito-business-intelligence-20220406-650-300-lse-life-sciences-europe.jpg)
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
